Clinical Trial Update: A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing duloxetine hydrochloride, a marketed comparator, and placebo for generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Duloxetine hydrochloride (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED